Covid19

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Covid19, SARS (Severe Acute Respiratory Syndrome), SARS Pneumonia Trial in Worldwide (Fostamatinib, Placebo)

Active, not recruiting
  • Covid19
  • +5 more
  • Orange, California
  • +46 more
Aug 9, 2022

Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)

Recruiting
  • Covid19
  • theraputic heparin
  • +4 more
  • Birmingham, Alabama
  • +101 more
Jun 28, 2022

Covid19 Trial in Argentina, Brazil, United States (rNAPc2, Heparin)

Completed
  • Covid19
  • Fairhope, Alabama
  • +23 more
May 25, 2022

Covid19 Trial in Brazil (Tofacitinib 10 mg, Placebo)

Completed
  • Covid19
  • Tofacitinib 10 mg
  • Placebo
  • Aracaju, Brazil
  • +16 more
Aug 2, 2021

Covid19, Thrombosis Trial in Barbalha, São Paulo, Bragança Paulista (Apixaban 2.5 MG, Placebo)

Recruiting
  • Covid19
  • Thrombosis
  • Apixaban 2.5 MG
  • Placebo
  • Barbalha, Ceará, Brazil
  • +3 more
Mar 15, 2021